Search

everythinglearnresearchcommunity

for

Search:↓

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

New drug uses show promise but need more research.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

GI197111X is best dissolved in Capmul MCM for trials.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

The link between anabolic agents and colorectal cancer risk is unclear.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Upadacitinib improved multiple immune-related conditions in one patient.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Thyroid receptor β can help develop new drugs to treat hair loss.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

Stopping alcohol after long-term use causes anxiety and changes brain chemicals.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.